[1] Hoshide S, Mogi M, Kario K.Hypertension in Asia: Genetic, lifestyle, and clinical insights[J]. Hypertens Res. 2024; 47(8):2007-2008.
[2] Kario K, Hoshide S, Mogi M.Hypertension treatment up-date on World Hypertension Day 2024: current status and future prospects in Asia[J]. Hypertens Res. 2024; 47(7):1763-1765.
[3] Dzau VJ, Hodgkinson CP.Precision Hypertension[J]. Hypertension. 2024; 81(4):702-708.
[4] Gallo G, Savoia C.Hypertension and Heart Failure: From Pathophysiology to Treatment[J]. Int J Mol Sci. 2024; 25(12):6661.
[5] Fujiwara A, Ozawa M, Sumida K, et al.LPIN1 is a new target gene for essential hypertension[J]. J Hypertens. 2022; 40(3):536-543.
[6] Kim JH, Thiruvengadam R.Hypertension in an ageing population: Diagnosis, mechanisms, collateral health risks, treatments, and clinical challenges[J]. Ageing Res Rev. 2024; 98:102344.
[7] Dzau VJ, Hodgkinson CP.Precision Hypertension[J]. Hypertension. 2024; 81(4):702-708.
[8] Miller JB, Hrabec D, Krishnamoorthy V, et al.Evaluation and management of hypertensive emergency[J]. BMJ. 2024; 386:e077205.
[9] Zhou F, Fan X, Miao Y.LPIN1 promotes triglycerides synthesis and is transcriptionally regulated by PPARG in buffalo mammary epithelial cells[J]. Sci Rep. 2022; 12(1):2390.
[10] Chu C, Chen C, Rajendran RS, et al.Overexpression of Akt1 enhances adipogenesis and leads to lipoma formation in zebrafish[J]. PLoS One, 2012, 7: e36474.
[11] Sellers RS, Mahmood SR, Perumal GS, et al.Phenotypic Modulation of Skeletal Muscle Fibers in LPIN1-Deficient Lipodystrophic ( fld) Mice[J]. Vet Pathol. 2019; 56(2):322-331.
[12] 娄满,高春燕,王宏业.miR-615-5p在高血压患者血清中表达及其调控Akt/eNOS信号通路的机制[J].中国老年学杂志,2022,42(17):4279-4284.
[13] Yu LP, Shi LY, Zhang MM, et al. [MicroRNA expression profile and pathogenetic initial study in essential hypertension][J]. Zhonghua Xin Xue Guan Bing Za Zhi.2011 Jun;39(6):488-93. Chinese. PMID: 21924071.
[14] Kontaraki JE, Marketou ME, Zacharis EA, et al. MicroRNA-9 and microRNA-126 expression levels in patients with essential hypertension: potential markers of target-organ damage[J]. J Am Soc Hypertens.2014 Jun;8(6):368-75.
[15] Perlini S, Grassi G. Hypertension-related target organ damage: is it a continuum?[J] J Hypertens.2013 Jun;31(6):1083-5. |
